Endovascular Intervention for Peripheral Artery Disease
Top Cited Papers
- 24 April 2015
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 116 (9), 1599-1613
- https://doi.org/10.1161/circresaha.116.303503
Abstract
Advances in endovascular therapies during the past decade have broadened the options for treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower risk alternative to open surgery in many patients with multiple comorbidities. Noninvasive physiological tests and arterial imaging precede an endovascular intervention and help localize the disease and plan the procedure. The timing and need for revascularization are broadly related to the 3 main clinical presentations of claudication, critical limb ischemia, and acute limb ischemia. Many patients with claudication can be treated by exercise and medical therapy. Endovascular procedures are considered when these fail to improve quality of life and function. In contrast, critical limb ischemia and acute limb ischemia threaten the limb and require more urgent revascularization. In general, endovascular treatments have greater long-term durability for aortoiliac disease than femoral popliteal disease. Infrapopliteal revascularization is generally reserved for critical and acute limb ischemia. Balloon angioplasty and stenting are the mainstays of endovascular therapy. New well-tested innovations include drug-eluting stents and drug-coated balloons. Adjunctive devices for crossing chronic total occlusions or debulking plaque with atherectomy are less rigorously studied and have niche roles. Patients receiving endovascular procedures need a structured surveillance plan for follow-up care. This includes intensive treatment of cardiovascular risk factors to prevent myocardial infarction and stroke, which are the main causes of death. Limb surveillance aims to identify restenosis and new disease beyond the intervened segments, both of which may jeopardize patency and lead to recurrent symptoms, functional impairment, or a threatened limb.Keywords
This publication has 123 references indexed in Scilit:
- Treatment of Complex Atherosclerotic Popliteal Artery Disease With a New Self-Expanding Interwoven Nitinol StentJACC: Cardiovascular Interventions, 2013
- A Prospective Randomized Multicenter Comparison of Balloon Angioplasty and Infrapopliteal Stenting With the Sirolimus-Eluting Stent in Patients With Ischemic Peripheral Arterial DiseaseJournal of the American College of Cardiology, 2012
- DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents in the common iliac artery: study protocol for a randomized controlled trialTrials, 2012
- A Budget Impact Model for Paclitaxel-eluting Stent in Femoropopliteal Disease in FranceCardioVascular and Interventional Radiology, 2012
- Femoral artery percutaneous revascularization for patients with critical limb ischemia: Outcomes compared to patients with claudication over 2.5 yearsVascular Medicine, 2012
- Long-Term Impact of Chronic Kidney Disease in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: The HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) TrialJACC: Cardiovascular Interventions, 2011
- A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive diseaseJournal of Vascular Surgery, 2011
- A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudicationVascular Medicine, 2010
- An Effective Guidewire Looping Technique for the Recanalization of Occlusive Segments of Infrapopliteal VesselsKorean Journal of Radiology, 2010
- Intermittent ClaudicationCirculation, 1970